Associations of plasma angiostatin and amyloid-β and tau levels in Alzheimer’s disease

Angiostatin, an endogenous angiogenesis inhibitor generated by the proteolytic cleavage of plasminogen, was recently reported to contribute to the development of Alzheimer’s disease (AD). However, whether there are pathological changes in angiostatin levels in individuals with AD dementia is unclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yuan, Ren, Jun-Rong, Jian, Jie-Ming, He, Chen-Yang, Xu, Man-Yu, Zeng, Gui-Hua, Tan, Cheng-Rong, Shen, Ying-Ying, Jin, Wang-Sheng, Chen, Dong-Wan, Li, Hui-Yun, Yi, Xu, Zhang, Yuan, Bu, Xian-Le, Wang, Yan-Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091258/
https://www.ncbi.nlm.nih.gov/pubmed/35538065
http://dx.doi.org/10.1038/s41398-022-01962-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091258/
https://www.ncbi.nlm.nih.gov/pubmed/35538065
http://dx.doi.org/10.1038/s41398-022-01962-6

Ejemplares similares